Filter
Period
Filter by
recent search
Showing: 1 – 05 of 114 Regulated Information
–
03 October 2023
03 October 2023
Ipsen updates on QM-1114 regulatory process
PARIS, FRANCE, 3 October 2023 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today that its partner Galderma has confirmed receipt from the FDA of a Complete Response Letter related to its Biologics License Application for liquid botulinum toxin type A…
–
26 September 2023
26 September 2023
LinkedIn
Twitter
Facebook
–
19 September 2023
19 September 2023
IPSEN – Buy-back programme – Art 5 of MAR – Week 37 – 2023
Aggregated presentation by day and by market
–
12 September 2023
12 September 2023
IPSEN – Buy-back programme – Art 5 of MAR – Week 36 – 2023
Aggregated presentation by day and by market
–
08 September 2023
08 September 2023
Ipsen – Monthly information relative to the total number of voting rights and shares composing the share capital
Monthly information relative to the total number of voting rightsand shares composing the share capital